ESPERVITA THERAPEUTICS
Dead / Abandoned — Abandoned — failure to respond (as of 14 Mar 2023)
What this means for you
This application is over — abandoned 01 Mar 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88300521
- Mark type
- Stylized text
- Filed
- 13 Feb 2019
- Published for opposition
- 18 Jun 2019
- Abandoned
- 01 Mar 2023
- Attorney of record
- Daniel Heaton
Goods and services
- Class 005 — Pharmaceuticals: A full line of medicated and pharmaceutical preparations, both prescription and over-the-counter, pertaining to metabolic disease and oncology
Owner
- Espervita Therapeutics, Inc., Saline, MI, US
- Espervita Therapeutics, Inc., Saline, MI, US
Prosecution history
- 14 Mar 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 14 Mar 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 14 Mar 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 31 Aug 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Aug 2022 — NON-FINAL ACTION E-MAILED
- 31 Aug 2022 — SU - NON-FINAL ACTION - WRITTEN
- 17 Aug 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 13 Aug 2022 — USE AMENDMENT FILED
- 13 Aug 2022 — TEAS STATEMENT OF USE RECEIVED
- 19 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Feb 2022 — SOU EXTENSION 5 GRANTED
- 11 Feb 2022 — SOU EXTENSION 5 FILED
- 18 Feb 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Feb 2022 — SOU TEAS EXTENSION RECEIVED
- 13 Aug 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED